Fortress Biotech Forms Gene-Therapy Subsidiary
By
Fortress Biotech, a New York-based biopharmaceutical company acquiring, developing, and commercializing pharmaceutical and biotechnology products, has formed Tamid Bio, a subsidiary dedicated to developing adeno-associated virus (AAV) gene therapies in…